<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PAPER
  SYSTEM "paper-structure-annotation.dtd">
<PAPER><mode2 name="b110865b" hasDoc="yes" version="1085"/><TITLE><s sid="1"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj1" novelty="New" advantage="None"/><text>Synthesis and binding properties of chiral macrocyclic barbiturate receptors: application to nitrile oxide cyclizations</text></s></TITLE><ABSTRACT><s sid="2"><CoreSc1 atype="GSC" type="Goa" conceptID="Goa1" novelty="None" advantage="None"/><text>A series of chiral macrocyclic receptors containing a barbiturate binding domain based on two 2,6-diaminopyridine groups has been synthesized with the purpose of exploiting these for asymmetric 1,3-dipolar cycloadditions.</text></s> <s sid="3"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>Each macrocyclic host was built possessing an (R)-BINOL or a modified deoxycholate moiety as the chiral unit connected to the barbiturate binding domain with varying lengths of spacer.</text></s> <s sid="4"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs1" novelty="None" advantage="None"/><text>All the hosts with the exception of one were found to effectively bind a barbiturate–cinnamic acid conjugate with association constants in the order of 104 M–1 in CDCl3.</text></s> <s sid="5"><CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/><text>The 1,3-dipolar cycloaddition between several arylnitrile oxides and the cinnamate conjugates were examined in the presence of stoichiometric amounts of a chiral receptor affording two regioisomeric isoxazolines.</text></s> <s sid="6"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs2" novelty="None" advantage="None"/><text>Enantiomeric excesses of up to 30percent were obtained in one case for the major regioisomer.</text></s> <s sid="7"><CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/><text>In most cases, the enantiomeric excesses could be measured directly from the crude 1H-NMR spectra owing to the diastereomeric interaction between the isoxazoline cycloadduct and the chiral receptor.</text></s> <s sid="8"><CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/><text>The relatively low enantiofacial selectivities at the CC double bond of the cinnamate were attributed to the non-planar orientation of the barbiturate–cinnamate conjugate with respect to the receptor, as previously noted for the binding of barbital<XREF ID="fn1" TYPE="FOOTNOTE_MARKER"/> to an achiral macrocyclic host (S.-K., Chang, E. Fan, D. Van Engen and A. D. Hamilton, J. Am.</text></s> <s sid="9"><CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/><text>Chem.</text></s> <s sid="10"><CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/><text>Soc., 1991, 113, 7640), directing the cinnamate unit away from the chiral unit.</text></s></ABSTRACT><BODY><DIV DEPTH="1"><HEADER>Introduction</HEADER><P><s sid="11"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/><text>A principal binding mode between a substrate undergoing chemical transformation and an enzyme, involves recognition through multiple weak intermolecular interactions such as hydrogen bonding.</text></s> <s sid="12"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/><text>This recognition event allows for a strong geometrically defined association of the substrate in the enzyme such that any activation or reaction with other active site functional groups becomes pseudo-intramolecular, thereby greatly increasing the rate of the process.</text></s> <s sid="13"><CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="Old" advantage="None"/><text>Whereas, there is ample literature precedence concerning studies using synthetic receptors capable of binding ligands with high association constants via multiple hydrogen bonding (i.e. molecular recognition);<REF ID="R-0" REFID="cit1a"/><REF ID="R-1" REFID="cit1b"/> more spectacular applications include the design of such systems for promoting organic synthetic transformations.<REF ID="R-2" REFID="cit2a"/><REF ID="R-3" REFID="cit2b"/><REF ID="R-4" REFID="cit2c"/></text></s></P><P><s sid="14"><CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="Old" advantage="Yes"/><text>The application of such receptors would be highly advantageous.<REF ID="R-5" REFID="cit3a"/><REF ID="R-6" REFID="cit3b"/><REF ID="R-7" REFID="cit3c"/></text></s> <s sid="15"><CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="Old" advantage="Yes"/><text>The fixed orientation of the substrate in the receptor would allow organic reactions to become regioselective; the selectivity is not only determined by intrinsic directive properties of the substrate itself but also by its orientation in the receptor.</text></s> <s sid="16"><CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="Old" advantage="Yes"/><text>This trait is a particularly important property of many enzymatic reactions.</text></s> <s sid="17">By designing a chiral receptor, it may also allow one face of the bound substrate to be shielded thus directing the desired reaction to occur at only one of the two enantiotopic faces of an achiral substrate.</s> <s sid="18"><CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="Old" advantage="Yes"/><text>In other words, chirality is transferred from the receptor to the substrate.</text></s></P><P><s sid="19"><CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="Old" advantage="None"/><text>An interesting host–guest system based on multiple hydrogen bonding is represented by Hamilton's previously reported complex of barbital <XREF ID="chem1" TYPE="COMPOUND">1</XREF> to the macrocyclic receptor or host, <XREF ID="chem2" TYPE="COMPOUND">2</XREF>, consisting of two 2,6-diaminopyridine units forming a cavity for <XREF ID="chem1" TYPE="COMPOUND">1</XREF> (<XREF ID="sch1" TYPE="SCHEME-REF">Scheme 1</XREF>).<REF ID="R-8" REFID="cit4a"/><REF ID="R-9" REFID="cit4b"/><REF ID="R-10" REFID="cit4c"/><REF ID="R-11" REFID="cit4d"/></text></s> <s sid="20"><CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="Old" advantage="None"/><text>The <XREF ID="chem2" TYPE="COMPOUND">2</XREF> ∶ <XREF ID="chem1" TYPE="COMPOUND">1</XREF> complex, exhibiting six hydrogen bonding interactions as revealed by its X-ray crystal structure, was found to possess a strong association constant (2.5 × 105 M–1 in CH2Cl2).<REF ID="R-12" REFID="cit4d"/></text></s> <s sid="21"><CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="Old" advantage="None"/><text>Because of this effective binding, numerous applications exploiting this host–guest system have therefore been put forth including models for transacylase enzymes,<REF ID="R-13" REFID="cit4c"/><REF ID="R-14" REFID="cit5a"/><REF ID="R-15" REFID="cit5b"/> organic gels,<REF ID="R-16" REFID="cit6"/> systems for the sensitive detection of barbiturates though fluorescence change, <REF ID="R-17" REFID="cit4b"/><REF ID="R-18" REFID="cit7a"/><REF ID="R-19" REFID="cit7b"/><REF ID="R-20" REFID="cit7c"/> models for studying electron transport,<REF ID="R-21" REFID="cit8"/> and others.<REF ID="R-22" REFID="cit9a"/><REF ID="R-23" REFID="cit9b"/><REF ID="R-24" REFID="cit9c"/></text></s></P><P><s sid="22"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj2" novelty="New" advantage="None"/><text>In this work, we examine the possibility of employing chiral receptors containing the same binding motif as the macrocyclic receptor <XREF ID="chem2" TYPE="COMPOUND">2</XREF> for asymmetric synthesis.</text></s> <s sid="23"><CoreSc1 atype="GSC" type="Res" conceptID="Res3" novelty="None" advantage="None"/><text>In particular, various macrocyclic chiral hosts <XREF ID="chem3a chem3b chem3c" TYPE="COMPOUND">3a–c</XREF>, <XREF ID="chem4" TYPE="COMPOUND">4</XREF>, <XREF ID="chem5" TYPE="COMPOUND">5</XREF> and <XREF ID="chem6" TYPE="COMPOUND">6</XREF> have been synthesized for the first time incorporating a (R)-BINOL or a C3,C3′-disubstituted (R)-BINOL unit, as well as a modified deoxycholic acid, as illustrated in <XREF ID="fig1" TYPE="FIGURE-REF">Fig. 1</XREF>.</text></s> <s sid="24"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj3" novelty="New" advantage="None"/><text>The ability of these hosts to bind a barbiturate–cinnamic acid conjugate has then been examined.</text></s> <s sid="25"><CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp1" novelty="None" advantage="None"/><text>It is our expectation that upon binding, the orientation of the barbiturate conjugate in the chiral host will place the cinnamate moiety proximate to the chiral environment, hence shielding one face of the CC double bond.</text></s> <s sid="26"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj4" novelty="New" advantage="None"/><text>To study this shielding effect, well-known 1,3-dipolar cycloadditions<REF ID="R-25" REFID="cit11"/><REF ID="R-26" REFID="cit12"/> employing arylnitrile oxides have been performed with a receptor bound cinnamate moiety, the results of which are discussed below.</text></s></P></DIV><DIV DEPTH="1"><HEADER>Results and discussion</HEADER><DIV DEPTH="2"><HEADER>Synthesis of the chiral receptors and the barbiturate–cinnamic acid conjugate</HEADER><P><s sid="27"><CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="Old" advantage="None"/><text>The BINOL-macrocycles <XREF ID="chem3a chem3b chem3c" TYPE="COMPOUND">3a–c</XREF> and <XREF ID="chem4" TYPE="COMPOUND">4</XREF> were synthesized employing a similar procedure reported for the preparation of receptor <XREF ID="chem2" TYPE="COMPOUND">2</XREF>.</text></s> <s sid="28"><CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="Old" advantage="None"/><text>In these receptors, the length of the spacer between the binding motif and the chiral unit has been varied in order to identify a host with the best binding properties for the barbiturate–cinnamate conjugate, as well as with the appropriate length for the proper placement of the cinnamate moiety with respect to the chiral unit.</text></s></P><P><s sid="29"><CoreSc1 atype="GSC" type="Met" conceptID="Met5" novelty="Old" advantage="None"/><text>Preparation of the diacid <XREF ID="chem8a" TYPE="COMPOUND">8a</XREF> started with the diallylation of (R)-BINOL<REF ID="R-27" REFID="cit13"/> with allyl bromide in the presence of potassium carbonate (<XREF ID="sch2" TYPE="SCHEME-REF">Scheme 2</XREF>).</text></s> <s sid="30"><CoreSc1 atype="GSC" type="Met" conceptID="Met5" novelty="Old" advantage="None"/><text>Subsequent hydroboration with 9-BBN and accompanying oxidation afforded the diol <XREF ID="chem7" TYPE="COMPOUND">7</XREF> in 88percent overall yield for the two steps.</text></s> <s sid="31"><CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="Old" advantage="None"/><text>Conversion of the diol to the dicarboxylic acid <XREF ID="chem8a" TYPE="COMPOUND">8a</XREF> was achieved by oxidation to the dialdehyde using the Dess–Martin periodinane<REF ID="R-28" REFID="cit14"/> and then finally to the diacid with sodium chlorite.</text></s> <s sid="32"><CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="Old" advantage="None"/><text>The homologs of this diacid, <XREF ID="chem8b" TYPE="COMPOUND">8b</XREF> and <XREF ID="chem8c" TYPE="COMPOUND">8c</XREF>, were easily prepared in two steps by alkylation of BINOL with ethyl 3-bromobutyrate or 5-bromovalerate, respectively, and then subsequent hydrolysis.</text></s> <s sid="33"><CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="Old" advantage="None"/><text>Macrocyclization proved successful by first converting the diacids to their corresponding diacid chlorides (oxalyl dichloride, DMF, CH2Cl2) and then subjecting them to one equivalent of the readily available diamine <XREF ID="chem10" TYPE="COMPOUND">10</XREF><REF ID="R-29" REFID="cit4d"/> in THF under high dilution conditions in the presence of triethylamine.</text></s> <s sid="34"><CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="Old" advantage="None"/><text>In this way, the crystalline chiral receptors <XREF ID="chem3a chem3b chem3c" TYPE="COMPOUND">3a–3c</XREF> were secured in good yields from 36–57percent for the two steps, after column chromatography.</text></s> <s sid="35"><CoreSc1 atype="GSC" type="Met" conceptID="Met7" novelty="Old" advantage="None"/><text>A similar sequence of events was used for the synthesis of the chiral host <XREF ID="chem4" TYPE="COMPOUND">4</XREF> embodying a 3,3′-dinaphthyl–BINOL unit, itself prepared in 6 steps from (R)-BINOL employing a Pd(0)-catalyzed Suzuki coupling reaction as the prime step.<REF ID="R-30" REFID="cit15"/></text></s></P><P><s sid="36"><CoreSc1 atype="GSC" type="Met" conceptID="Met8" novelty="New" advantage="None"/><text>The spacial arrangement of the two secondary hydroxy groups in deoxycholic acid (distance = 6 Å)<REF ID="R-31" REFID="cit16"/> suggested the possibility of exploiting this steroid for the generation of a chiral but non-C2-symmetrical macrocyclic barbiturate binding receptor.</text></s> <s sid="37"><CoreSc1 atype="GSC" type="Met" conceptID="Met8" novelty="New" advantage="None"/><text>To achieve this goal, the corresponding methyl ester was reduced and tritylated to afford the monoprotected triol <XREF ID="chem11" TYPE="COMPOUND">11</XREF> (<XREF ID="sch3" TYPE="SCHEME-REF">Scheme 3</XREF>).</text></s> <s sid="38"><CoreSc1 atype="GSC" type="Met" conceptID="Met8" novelty="New" advantage="None"/><text>Subsequent chain extension proceeded as previously described for the synthesis of the macrocycle <XREF ID="chem3a" TYPE="COMPOUND">3a</XREF> affording the dicarboxylic acid <XREF ID="chem13" TYPE="COMPOUND">13</XREF>.</text></s> <s sid="39"><CoreSc1 atype="GSC" type="Met" conceptID="Met8" novelty="New" advantage="No"/><text>Nevertheless, several attempts to promote the cyclization under high dilution conditions between the corresponding acid chloride of <XREF ID="chem13" TYPE="COMPOUND">13</XREF> with diamine <XREF ID="chem10" TYPE="COMPOUND">10</XREF> only led to trace amounts of the desired macrocycle <XREF ID="chem14" TYPE="COMPOUND">14</XREF>.</text></s> <s sid="40"><CoreSc1 atype="GSC" type="Met" conceptID="Met9" novelty="New" advantage="None"/><text>Reversing the roles of the acylating agent, however proved more rewarding.</text></s> <s sid="41"><CoreSc1 atype="GSC" type="Met" conceptID="Met9" novelty="New" advantage="None"/><text>Hence, treatment of the diamine <XREF ID="chem10" TYPE="COMPOUND">10</XREF> with phosgene and triethylamine followed by the slow addition of the diol <XREF ID="chem12" TYPE="COMPOUND">12</XREF> at room temperature resulted in a 15percent yield of the macrocyclic dicarbamate <XREF ID="chem6" TYPE="COMPOUND">6</XREF>.</text></s> <s sid="42"><CoreSc1 atype="GSC" type="Met" conceptID="Met10" novelty="New" advantage="None"/><text>Encouraged by this result we could likewise extend this cyclization approach to the synthesis of the smaller macrocycle <XREF ID="chem5" TYPE="COMPOUND">5</XREF> in 12percent yield in one step from methyl deoxycholate.</text></s> <s sid="43"><CoreSc1 atype="GSC" type="Met" conceptID="Met10" novelty="New" advantage="None"/><text>In this latter case, it was necessary to slowly add the methyl deoxycholate to a refluxing solution of the phosgene-pretreated diamine in order to obtain the desired macrocycle.</text></s> <s sid="44"><CoreSc1 atype="GSC" type="Met" conceptID="Met10" novelty="New" advantage="None"/><text>In contrast, fast addition of the steroid only led to a product composed of the diamine <XREF ID="chem10" TYPE="COMPOUND">10</XREF> coupled to two deoxycholate units according to ES-MS, whereas attempted ring formation at room temperature afforded no cyclic products signalling a high ring tension in this small macrocyclic structure.</text></s> <s sid="45"><CoreSc1 atype="GSC" type="Met" conceptID="Met10" novelty="New" advantage="None"/><text>Effort was also made to prepare <XREF ID="chem5" TYPE="COMPOUND">5</XREF> by the direct coupling of the diamine <XREF ID="chem10" TYPE="COMPOUND">10</XREF> with the crystalline bis(imidazolylcarbonyl) functionalized deoxycholate,<REF ID="R-32" REFID="cit18"/> although in vain.</text></s></P><P><s sid="46"><CoreSc1 atype="GSC" type="Met" conceptID="Met11" novelty="New" advantage="None"/><text>With the chiral hosts in hand, the barbiturate–cinnamate substrates were then accessed from the readily available 5-isopropyl-, 5-methyl- and 5-phenyl- barbituric acids <XREF ID="chem15a chem15b chem15c" TYPE="COMPOUND">15a–c</XREF> as shown in <XREF ID="sch4" TYPE="SCHEME-REF">Scheme 4</XREF>.<REF ID="R-33" REFID="cit19"/></text></s> <s sid="47"><CoreSc1 atype="GSC" type="Met" conceptID="Met11" novelty="New" advantage="None"/><text>Introduction of a linker for the cinnamic acid was easily achieved by subjecting <XREF ID="chem15a chem15b chem15c" TYPE="COMPOUND">15a–c</XREF> to aqueous formaldehyde under acidic conditions affording the primary alcohols <XREF ID="chem16a chem16c" TYPE="COMPOUND">16a,c</XREF> in high yields, whereas the greater water solubility of <XREF ID="chem16b" TYPE="COMPOUND">16b</XREF> resulted in a reduced yield.<REF ID="R-34" REFID="cit20"/></text></s> <s sid="48"><CoreSc1 atype="GSC" type="Met" conceptID="Met11" novelty="New" advantage="None"/><text>Although base-promoted acylation with cinnamoyl chloride only led to concomitant deformylation, refluxing a THF solution of <XREF ID="chem16a chem16b chem16c" TYPE="COMPOUND">16a–c</XREF> with excess acid chloride generated the desired esters <XREF ID="chem17a chem17b chem17c" TYPE="COMPOUND">17a–c</XREF> in good yields of 82–90percent.</text></s></P></DIV><DIV DEPTH="2"><HEADER>Binding properties of the chiral receptors</HEADER><P><s sid="49"><CoreSc1 atype="GSC" type="Goa" conceptID="Goa2" novelty="None" advantage="None"/><text>Our first concern was whether the chiral hosts could effectively bind to complementary barbiturate substrates, being a prerequisite for the subsequent asymmetric dipolar cycloaddition studies.</text></s> <s sid="50"><CoreSc1 atype="GSC" type="Met" conceptID="Met12" novelty="Old" advantage="None"/><text>Titration experiments in CDCl3 were therefore performed between the receptor and substrate measuring the characteristic large downfield shifts of the host's amide NH's (approx.</text></s> <s sid="51"><CoreSc1 atype="GSC" type="Met" conceptID="Met12" novelty="Old" advantage="None"/><text>1.5 ppm) as a function of the barbiturate concentration.</text></s> <s sid="52"><CoreSc1 atype="GSC" type="Met" conceptID="Met12" novelty="Old" advantage="None"/><text>From the titration curve, the association constant (Ka) can therefore be extracted according to that previously reported.<REF ID="R-35" REFID="cit4d"/></text></s> <s sid="53"><CoreSc1 atype="GSC" type="Met" conceptID="Met12" novelty="Old" advantage="None"/><text>Although, there is some uncertainty associated with the measured values of Ka higher than 104 M–1 employing NMR techniques,<REF ID="R-36" REFID="cit21"/> the precision is nevertheless adequate for our purposes, providing us with a general idea of the percentage of binding.</text></s></P><P><s sid="54"><CoreSc1 atype="GSC" type="Res" conceptID="Res4" novelty="None" advantage="None"/><text>The association constants found are shown in <XREF ID="tab1" TYPE="TABLE-REF">Table 1</XREF>.</text></s> <s sid="55"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/><text>The known receptor <XREF ID="chem2" TYPE="COMPOUND">2</XREF> has previously been reported to bind barbital <XREF ID="chem1" TYPE="COMPOUND">1</XREF> with a Ka value of 2.5 × 105 M–1 in CH2Cl2.<REF ID="R-37" REFID="cit4d"/></text></s> <s sid="56"><CoreSc1 atype="GSC" type="Res" conceptID="Res5" novelty="None" advantage="None"/><text>Through titration studies and curve fitting, it was satisfying to see that a similar result was also obtained with barbital and the host <XREF ID="chem3c" TYPE="COMPOUND">3c</XREF> which displays the closest resemblance to <XREF ID="chem2" TYPE="COMPOUND">2</XREF>.<REF ID="R-38" REFID="cit23"/></text></s> <s sid="57"><CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/><text>In spite of the fact that a small decrease in the Ka was noted for the barbiturate conjugate <XREF ID="chem17a" TYPE="COMPOUND">17a</XREF> (Ka = 7.0 × 104 M–1), being the sterically most demanding of the three barbiturates synthesized, this value was still sufficiently high and encouraging for subsequent studies.</text></s> <s sid="58"><CoreSc1 atype="GSC" type="Res" conceptID="Res7" novelty="None" advantage="None"/><text>Measurements made with this conjugate and receptors <XREF ID="chem3a" TYPE="COMPOUND">3a</XREF> and <XREF ID="chem3b" TYPE="COMPOUND">3b</XREF>, revealed a slight decrease in the binding constant, possibly owing to the smaller ring size and hence more rigid nature of these hosts.</text></s> <s sid="59"><CoreSc1 atype="GSC" type="Res" conceptID="Res8" novelty="None" advantage="None"/><text>The deoxycholate containing macrocycle <XREF ID="chem6" TYPE="COMPOUND">6</XREF> also proved satisfactory, displaying an affinity for <XREF ID="chem3c" TYPE="COMPOUND">3c</XREF> with Ka = 5.2 × 104 M–1.</text></s></P><P><s sid="60"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/><text>It was somewhat surprising to see that the smaller counterpart to <XREF ID="chem6" TYPE="COMPOUND">6</XREF>, namely the receptor <XREF ID="chem5" TYPE="COMPOUND">5</XREF>, appears to bind two molecules of <XREF ID="chem3c" TYPE="COMPOUND">3c</XREF>.</text></s> <s sid="61"><CoreSc1 atype="GSC" type="Met" conceptID="Met13" novelty="Old" advantage="None"/><text>This was demonstrated through the application of a standard protocol, the Job method, for the stoichiometry determination between a receptor (R) and its ligand (L).<REF ID="R-39" REFID="cit1b"/></text></s> <s sid="62"><CoreSc1 atype="GSC" type="Met" conceptID="Met13" novelty="Old" advantage="None"/><text>As illustrated in <XREF ID="fig2" TYPE="FIGURE-REF">Fig. 2</XREF>, the complexation stoichiometry is easily determined at the maximum, obtained by plotting at a fixed total concentration ([R] + [L]), the observed change in the chemical shift of the amide or carbamate protons (Δδ(NH)) of the receptor, multiplied by the mole fraction, x = [R]/([R] + [L]), as a function of the mole fraction, x.<REF ID="R-40" REFID="cit24"/></text></s> <s sid="63"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/><text>As seen with the receptor <XREF ID="chem3c" TYPE="COMPOUND">3c</XREF>, the peaks of the curves are observed at a mole fraction of 0.5 indicating a 1 ∶ 1 stoichiometry for the complex as expected.</text></s> <s sid="64"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/><text>On the other hand, the macrocycle <XREF ID="chem5" TYPE="COMPOUND">5</XREF> reveals a maximum at approx.</text></s> <s sid="65"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/><text>0.38 suggesting that in this case two of the barbiturate conjugates are recognized and bound by the same receptor.</text></s> <s sid="66"><CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/><text>As to the mode of this binding, we can only speculate that the small ring size and steric congestion of the deoxycholate fragment in <XREF ID="chem5" TYPE="COMPOUND">5</XREF> arranges the two pyridyl units in a coplanar orientation upon binding rather than both occupying the same plane.</text></s> <s sid="67"><CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/><text>Hence, each diaminopyridine unit binds separately to a barbiturate via a hydrogen bonding network consisting of only three contact points rather than the usual six.<REF ID="R-41" REFID="cit25"/></text></s></P><P><s sid="68"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs5" novelty="None" advantage="None"/><text>The barbiturate conjugates <XREF ID="chem17b" TYPE="COMPOUND">17b</XREF> and <XREF ID="chem17c" TYPE="COMPOUND">17c</XREF> proved to be only slightly soluble in either of the two solvents dichloromethane or deuteriochloroform.</text></s> <s sid="69"><CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/><text>Whereas, the association constants were not measured with the above chiral receptors, we have noted that in the presence of one equivalent of the macrocycle <XREF ID="chem3c" TYPE="COMPOUND">3c</XREF> a clear solution was obtained in the deuteriochloroform, suggesting complexation is also achieved with these barbiturates.</text></s></P></DIV><DIV DEPTH="2"><HEADER>Studies of the nitrile oxide addition to the barbiturate–cinnamate conjugate in the presence of chiral receptors</HEADER><P><s sid="70"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj5" novelty="New" advantage="None"/><text>To evaluate the ability of the synthetic receptors to transfer chirality to the barbiturate–cinnamic acid conjugate, 1,3-dipolar cycloadditions were studied between an arylnitrile oxide and the cinnamoyl group of <XREF ID="chem17a chem17b chem17c" TYPE="COMPOUND">17a–c</XREF> in the presence of a stoichiometric quantity of the hosts <XREF ID="chem3a chem3b chem3c" TYPE="COMPOUND">3a–c</XREF> and <XREF ID="chem4 chem5 chem6" TYPE="COMPOUND">4–6</XREF>.<REF ID="R-42" REFID="cit10e"/><REF ID="R-43" REFID="cit26a"/><REF ID="R-44" REFID="cit26b"/><REF ID="R-45" REFID="cit26c"/><REF ID="R-46" REFID="cit26d"/><REF ID="R-47" REFID="cit26e"/><REF ID="R-48" REFID="cit26f"/><REF ID="R-49" REFID="cit26g"/><REF ID="R-50" REFID="cit26h"/><REF ID="R-51" REFID="cit26i"/><REF ID="R-52" REFID="cit26j"/><REF ID="R-53" REFID="cit26k"/><REF ID="R-54" REFID="cit26l"/><REF ID="R-55" REFID="cit26m"/><REF ID="R-56" REFID="cit26n"/><REF ID="R-57" REFID="cit26o"/><REF ID="R-58" REFID="cit26p"/><REF ID="R-59" REFID="cit26q"/><REF ID="R-60" REFID="cit26r"/><REF ID="R-61" REFID="cit26s"/><REF ID="R-62" REFID="cit26t"/></text></s> <s sid="71"><CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp2" novelty="None" advantage="None"/><text>As the above titration experiments clearly demonstrated the ability of the conjugate to bind well to the prepared receptors, it was anticipated that the cinnamoyl fragment would be oriented in close proximity to the asymmetric unit, thereby shielding one of the two enantiotopic faces of the CC double bond (<XREF ID="fig3" TYPE="FIGURE-REF">Fig. 3</XREF>).</text></s></P><P><s sid="72"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs6" novelty="None" advantage="None"/><text>The results of this study are depicted in <XREF ID="tab2" TYPE="TABLE-REF">Table 2</XREF>.</text></s> <s sid="73"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs7" novelty="None" advantage="None"/><text>The cycloaddition of the cinnamoyl derivative <XREF ID="chem17a" TYPE="COMPOUND">17a</XREF> with benzonitrile oxide, generated in situ from the corresponding chlorooxime upon addition of one equivalent of triethylamine, performed well in the absence of a receptor affording a racemic mixture of the two regioisomeric 2-isoxazolines <XREF ID="chem18a" TYPE="COMPOUND">18a</XREF> and <XREF ID="chem19a" TYPE="COMPOUND">19a</XREF> in 95percent yield and in a 5.5 to 1 ratio in favor of the 5-phenyl isomer <XREF ID="chem15a" TYPE="COMPOUND">15a</XREF> (entry 1).</text></s> <s sid="74"><CoreSc1 atype="GSC" type="Res" conceptID="Res9" novelty="None" advantage="None"/><text>This ratio is similar to the 4 ∶ 1 ratio for similar isoxazolines prepared from the addition of benzonitrile oxide to methyl cinnamate in EtOAc.<REF ID="R-63" REFID="cit27"/></text></s> <s sid="75"><CoreSc1 atype="GSC" type="Met" conceptID="Met14" novelty="New" advantage="None"/><text>Repetition of the cycloadditions in the presence of a chiral host was carried out by first premixing the receptor with the substrate and stirring for 15 min in CH2Cl2 allowing complexation to occur, followed by the addition of Et3N and the chlorooxime.</text></s> <s sid="76"><CoreSc1 atype="GSC" type="Met" conceptID="Met14" novelty="New" advantage="None"/><text>After stirring for 24 hours at room temperature the reaction was stopped and separation of products <XREF ID="chem18" TYPE="COMPOUND">18</XREF> and <XREF ID="chem19" TYPE="COMPOUND">19</XREF> from the receptor could be accomplished by flash chromatography.</text></s> <s sid="77"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs8" novelty="None" advantage="None"/><text>Typically 85–95percent of the chiral host was recovered and a conversion of approximately 50–70percent of the cinnamate conjugate was observed.</text></s> <s sid="78"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/><text>Although, it was expected that the presence of the triethylamine would have some influence on the binding of the barbiturate to the host, it has previously been shown that small amounts of base do not significantly perturb the binding constants for these hydrogen bonding interactions.<REF ID="R-64" REFID="cit9b"/></text></s></P><P><s sid="79"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/><text>In the reaction between cinnamate <XREF ID="chem17a" TYPE="COMPOUND">17a</XREF> and benzonitrile oxide in the presence of receptor <XREF ID="chem3a" TYPE="COMPOUND">3a</XREF> or <XREF ID="chem3b" TYPE="COMPOUND">3b</XREF>, no enantioselective induction was observed in either of the products <XREF ID="chem18a" TYPE="COMPOUND">18a</XREF> or <XREF ID="chem19a" TYPE="COMPOUND">19a</XREF> as determined by chiral HPLC analysis (entries 2 and 3).</text></s> <s sid="80"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/><text>Nevertheless, an approximate two fold decrease in the regioselectivity of the cycloaddition was noted for these receptors compared to the same reaction in the absence of the host.</text></s> <s sid="81"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/><text>On the other hand, with the more flexible receptor <XREF ID="chem3c" TYPE="COMPOUND">3c</XREF>, the cycloadduct <XREF ID="chem18a" TYPE="COMPOUND">18a</XREF> could be isolated possessing a low but measurable enantiomeric excess of 17percent, whereas its regioisomer <XREF ID="chem19a" TYPE="COMPOUND">19a</XREF> proved to be racemic (entry 4).</text></s> <s sid="82"><CoreSc1 atype="GSC" type="Res" conceptID="Res10" novelty="None" advantage="None"/><text>The choice of solvent proved critical as no asymmetric induction in <XREF ID="chem18a" TYPE="COMPOUND">18a</XREF> was observed when the cycloaddition reaction was performed in THF (entry 5).</text></s> <s sid="83"><CoreSc1 atype="GSC" type="Res" conceptID="Res11" novelty="None" advantage="None"/><text>Expecting an increase in the enantioselectivity upon use of host <XREF ID="chem4" TYPE="COMPOUND">4</XREF> possessing both C3,C3′-substitutents on the BINOL unit, it was somewhat surprising to isolate only racemic <XREF ID="chem18a" TYPE="COMPOUND">18a</XREF> upon completion of the cycloaddition (entry 6) considering the ability of the barbiturate conjugate to effectively bind to <XREF ID="chem4" TYPE="COMPOUND">4</XREF> (<XREF ID="tab1" TYPE="TABLE-REF">Table 1</XREF>).</text></s></P><P><s sid="84"><CoreSc1 atype="GSC" type="Met" conceptID="Met15" novelty="New" advantage="None"/><text>The effect on the asymmetric induction in the cycloadditions with the host <XREF ID="chem3c" TYPE="COMPOUND">3c</XREF> and the cinnamate <XREF ID="chem17a" TYPE="COMPOUND">17a</XREF> was also examined employing bulkier 1,3-dipoles, such as the 4-(t-Bu)benzo and the 2-naphthonitrile oxides (entries 7 and 9).</text></s> <s sid="85"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs10" novelty="None" advantage="None"/><text>With the latter, a substantial increase in the enantiomeric excess was observed with the formation of the cycloadduct <XREF ID="chem18b" TYPE="COMPOUND">18b</XREF> possessing a 31percent ee (entry 10), whereas no increase was noted in the isoxazoline product <XREF ID="chem18e" TYPE="COMPOUND">18e</XREF> from 4-(t-Bu)benzonitrile oxide (entry 8).</text></s> <s sid="86"><CoreSc1 atype="GSC" type="Met" conceptID="Met15" novelty="New" advantage="None"/><text>Subsequent studies were therefore carried out with the 2-naphthonitrile oxide.</text></s></P><P><s sid="87"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs11" novelty="None" advantage="None"/><text>It is interesting to note that of the two barbiturate–cinnamate conjugates <XREF ID="chem17b" TYPE="COMPOUND">17b</XREF> and <XREF ID="chem17c" TYPE="COMPOUND">17c</XREF>, the latter displays limited solubility in CH2Cl2, resulting in no production of cycloadducts when the reaction was performed in the absence of a receptor (entries 11 and 13).</text></s> <s sid="88"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs11" novelty="None" advantage="None"/><text>However, in the presence of one equivalent of the macrocycle <XREF ID="chem3c" TYPE="COMPOUND">3c</XREF>, the products <XREF ID="chem18d chem18e" TYPE="COMPOUND">18d,e</XREF> and <XREF ID="chem19d chem19e" TYPE="COMPOUND">19d,e</XREF> were isolated in combined yields of 80percent and 57percent (entries 12 and 14).</text></s> <s sid="89"><CoreSc1 atype="GSC" type="Res" conceptID="Res12" novelty="None" advantage="None"/><text>In these cases, both <XREF ID="chem18d" TYPE="COMPOUND">18d</XREF> and <XREF ID="chem18e" TYPE="COMPOUND">18e</XREF> furnished lower enantiomeric excesses of approx 13percent ee suggesting different binding modes for these cinnamate conjugates in the host <XREF ID="chem3c" TYPE="COMPOUND">3c</XREF> compared to <XREF ID="chem18a" TYPE="COMPOUND">18a</XREF>.</text></s> <s sid="90"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs12" novelty="None" advantage="None"/><text>Surprisingly, with the barbiturate <XREF ID="chem17b" TYPE="COMPOUND">17b</XREF> a profound influence on the regioselectivity (&gt;10 ∶ 1) was observed (entry 12).</text></s> <s sid="91"><CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/><text>Nonetheless, these latter results lead to the important conclusion that at least with receptor <XREF ID="chem3c" TYPE="COMPOUND">3c</XREF>, the cycloadditions are indeed taking place with a barbiturate–cinnamate–receptor complex and not only with unbound <XREF ID="chem17" TYPE="COMPOUND">17</XREF> in equilibrium with the bound complex <XREF ID="chem17" TYPE="COMPOUND">17</XREF>–<XREF ID="chem3c" TYPE="COMPOUND">3c</XREF>.</text></s></P><P><s sid="92"><CoreSc1 atype="GSC" type="Met" conceptID="Met16" novelty="New" advantage="None"/><text>Finally, the cycloaddition reactions carried out on the conjugate <XREF ID="chem17c" TYPE="COMPOUND">17c</XREF> and 2-naphthonitrile oxide were also examined in the presence of the deoxycholate based receptors <XREF ID="chem5" TYPE="COMPOUND">5</XREF> and <XREF ID="chem6" TYPE="COMPOUND">6</XREF> (entries 15 and 16).</text></s> <s sid="93"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs13" novelty="None" advantage="None"/><text>Only in the latter case was a notable enantiomeric excess observed for the major regioisomer, the preference of which proved to be the same as that observed for the host <XREF ID="chem3c" TYPE="COMPOUND">3c</XREF>.</text></s></P><P><s sid="94"><CoreSc1 atype="GSC" type="Con" conceptID="Con5" novelty="None" advantage="None"/><text>As a final remark to the cycloaddition studies, it is interesting to note our ability to directly measure the enantiomeric excesses of the cycloadducts <XREF ID="chem18" TYPE="COMPOUND">18</XREF> from the 1H-NMR spectra of the crude reaction mixtures due to the diastereomeric interaction of the barbiturate–isoxazoline conjugates with the chiral receptors.</text></s> <s sid="95"><CoreSc1 atype="GSC" type="Met" conceptID="Met17" novelty="New" advantage="None"/><text>In general, both protons at either C4 or C5 of each of the enantiomeric isoxazoline products in the presence of the receptor could be identified on the 1H-NMR spectrum, whereafter the enantiomeric excess was determined by simple integration.</text></s> <s sid="96"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs14" novelty="None" advantage="None"/><text>This is illustrated in <XREF ID="fig4" TYPE="FIGURE-REF">Fig. 4</XREF> in the analysis of the reaction between the 2-naphthonitrile oxide and cinnamate <XREF ID="chem17a" TYPE="COMPOUND">17a</XREF>.</text></s> <s sid="97"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs14" novelty="None" advantage="None"/><text>In the absence of a receptor, both the C4 and C5 of the isoxazoline product <XREF ID="chem18d" TYPE="COMPOUND">18d</XREF> are found as doublets at 5.97 and 4.53 ppm, respectively (<XREF ID="fig4" TYPE="FIGURE-REF">Fig. 4a</XREF>).</text></s> <s sid="98"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs15" novelty="None" advantage="None"/><text>When the reaction is performed in the presence of receptor <XREF ID="chem3c" TYPE="COMPOUND">3c</XREF> sufficient line separation of the C5-protons is observed and an enantiomeric excess of approx.</text></s> <s sid="99"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs15" novelty="None" advantage="None"/><text>30percent can be measured, corresponding to the 31percent obtained by HPLC.</text></s> <s sid="100"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs16" novelty="None" advantage="None"/><text>On the other hand, with receptor <XREF ID="chem5" TYPE="COMPOUND">5</XREF> the C4-protons are separated showing approximately a 5percent ee for the cycloadducts <XREF ID="chem18d" TYPE="COMPOUND">18d</XREF>.</text></s></P><P><s sid="101"><CoreSc1 atype="GSC" type="Res" conceptID="Res13" novelty="None" advantage="None"/><text>A potential explanation for the relatively low enantioselectivities observed in these 1,3-dipolar cycloadditions may be sought from a previous X-ray structure of a host ∶ barbital complex (<XREF ID="chem2" TYPE="COMPOUND">2</XREF> ∶ <XREF ID="chem1" TYPE="COMPOUND">1</XREF>).<REF ID="R-65" REFID="cit4d"/></text></s> <s sid="102"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/><text>In this structure, the barbital is not in a coplanar orientation with respect to the macrocycle, but is tilted at an angle of 27° relative to the plane of the pyridine rings.</text></s> <s sid="103"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/><text>Recently, two other receptor ∶ barbiturate structures have been reported revealing the same tendency.<REF ID="R-66" REFID="cit29"/></text></s> <s sid="104"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/><text>This non-coplanarity was attributed to the narrowness of the binding cavity and unfavorable interactions between the isophthaloyl C2-proton and the barbital C2-carbonyl group.</text></s> <s sid="105"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/><text>As a consequence of this orientation one of the two ethyl groups of barbital is projected away from, and at an approximate 90° angle to the naphthyl ring.</text></s> <s sid="106"><CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/><text>It is more than likely that the same non-coplanarity will be observed with the barbiturate–cinnamate conjugates and the chiral macrocyclic hosts synthesized, which may even be amplified by the possibly smaller size of their binding cavity compared to receptor <XREF ID="chem2" TYPE="COMPOUND">2</XREF> due to both the lengths of the linkers and the smaller distance between the two connecting oxygens in BINOL and deoxycholate compared to 2,7-dihydroxynaphthalene.</text></s> <s sid="107"><CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/><text>Unfortunately, we have not been able to obtain suitable crystals of any of these complexes for X-ray structural analysis.</text></s> <s sid="108"><CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/><text>However, if the cinnamate moiety is also oriented in an approx.</text></s> <s sid="109"><CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/><text>90° angle to the receptor upon binding of the conjugate to these hosts, the influence of the chiral unit may be small upon reaction with the arylnitrile oxides.</text></s> <s sid="110"><CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/><text>Support for this hypothesis may also be sought from the absence of any enantioselectivity observed in the formation of the regioisomeric isoxazolines <XREF ID="chem19" TYPE="COMPOUND">19</XREF>.</text></s> <s sid="111"><CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp3" novelty="None" advantage="None"/><text>It was initially assumed that this regioisomer would reveal the highest ee upon cyclization as the aryl fragment of the nitrile oxide was anticipated to be in close contact with the chiral subunit.</text></s> <s sid="112"><CoreSc1 atype="GSC" type="Con" conceptID="Con7" novelty="None" advantage="None"/><text>However, this cyclization mode would place the aryl fragment even further away from the chiral unit compared to that in the formation of the isoxazolines <XREF ID="chem18" TYPE="COMPOUND">18</XREF>.</text></s></P></DIV></DIV><DIV DEPTH="1"><HEADER>Experimental</HEADER><DIV DEPTH="2"><HEADER>General Methods</HEADER><P><s sid="113"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/><text>NMR spectra (1H at 200 MHz and 13C at 50 MHz) were recorded on a Varian Gemini 2000 spectrometer.</text></s> <s sid="114"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/><text>Chemical shifts (δ in ppm) are given relative to those for Me4Si; J-values are given in Hz.</text></s> <s sid="115"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/><text>ES mass spectra were recorded with a Micromass LC-TOF instrument.</text></s> <s sid="116"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp3" novelty="None" advantage="None"/><text>TLC was performed on Kieselgel 60 F254 (Merck).</text></s> <s sid="117"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp4" novelty="None" advantage="None"/><text>Dichloromethane was freshly distilled from calcium hydride, THF from sodium–benzophenone, whereas DMF was distilled under reduced pressure and stored over 4 Å molecular sieves.</text></s> <s sid="118"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp5" novelty="None" advantage="None"/><text>The diamine <XREF ID="chem10" TYPE="COMPOUND">10</XREF> was prepared following a previously published procedure.<REF ID="R-67" REFID="cit4d"/></text></s> <s sid="119"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/><text>Enantiomeric excesses were determined by HPLC on a Chiralpak AD column using n-hexane–isopropanol mixtures as eluent.</text></s> <s sid="120"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/><text>The specific optical rotations were measured in units of 10–1 deg cm2 g–1.</text></s> <s sid="121"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/><text>The 1H-NMR binding studies and the Job plots were performed employing standard methods<REF ID="R-68" REFID="cit31"/>.</text></s></P></DIV><DIV DEPTH="2"><HEADER>(R)-2,2′-Bis(3-hydroxypropoxy)-1,1′-binaphthyl (<XREF ID="chem7" TYPE="COMPOUND">7</XREF>)</HEADER><P><s sid="122"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>A mixture of (R)-BINOL (573 mg, 2.00 mmol), allyl bromide (968 mg, 8.00 mmol) and K2CO3 (829 mg, 6.00 mmol) was refluxed for 2 hours in dry acetone (12 mL).</text></s> <s sid="123"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>The solvent was removed under vacuum and the residue was partitioned between CH2Cl2 and water.</text></s> <s sid="124"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>The organic layer was separated, dried with Mg2SO4 and evaporated to give the di-O-allylated BINOL as a white powder (724 mg, 99percent).</text></s></P><P><s sid="125"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>The crude allyl ether was redissolved in dry THF (10 mL), 9-BBN (5.0 mL, 2.5 mmol, 0.5 M in THF) was added and the solution was stirred for 1 hour at 20 °C.</text></s> <s sid="126"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>After cooling in an ice bath, 33percent aqueous NaOH (2.0 mL) and 35percent aqueous H2O2 (2.0 mL) were carefully added and the mixture was refluxed for 1 h.</text></s> <s sid="127"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>The solution was partitioned between ether and brine, and the aqueous phase was extracted once more with ether.</text></s> <s sid="128"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>The combined organic phases were dried (Mg2SO4) and evaporated to dryness.</text></s> <s sid="129"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>The residue was purified by flash chromatography (CH2Cl2 ∶ acetone, 9 ∶ 1 to 7 ∶ 1) to give <XREF ID="chem7" TYPE="COMPOUND">7</XREF> as a white powder (703 mg, 88percent); <datasection id="o1656" type="dataSection">δH (CDCl3) 1.48–1.74 (4H, m, 2 × –CH2–), 2.43 (2H, br s, 2 × –OH), 3.18–3.30 (4H, m, 2 × –CH2OH), 3.95–4.22 (4H, m, 2 × –CH2OAr), 7.08–7.34 (6H, m, ArH), 7.41 (2H, d, J 8.8, ArH), 7.84 (2H, br d, J 8.1, ArH), 7.94 (2H, d, J 8.8, ArH); δC (CDCl3) 31.8, 59.9, 67.4, 114.7, 119.6, 123.7, 125.0, 126.3, 127.9, 129.2, 129.5, 133.7, 153.7; HR-MS (ES) calc. for C26H26O4Na (M + Na): 425.1729, found 425.1724.</datasection></text></s></P></DIV><DIV DEPTH="2"><HEADER>(R)-2,2′-Bis(2-carboxyethoxy)-1,1′-binaphthyl (<XREF ID="chem8a" TYPE="COMPOUND">8a</XREF>)</HEADER><P><s sid="130"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>Diol <XREF ID="chem7" TYPE="COMPOUND">7</XREF> (559 mg, 1.39 mmol) was stirred with the Dess–Martin periodinane (1.41 g, 3.33 mmol) in CH2Cl2 (10 mL) for 30 minutes.</text></s> <s sid="131"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>The organic phase was shaken with aqueous NaHCO3 (sat.), containing 5 g of Na2S2O3, until both phases became clear.</text></s> <s sid="132"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>The organic phase was separated and washed with aqueous NaHCO3 (sat.) followed by H2O, and then dried (Mg2SO4) and evaporated to dryness to give the crude dialdehyde.</text></s></P><P><s sid="133"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>The dialdehyde was redissolved in t-BuOH (50 mL), and isobutylene (ca.</text></s> <s sid="134"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>10 g) in THF (100 mL) was added together with NaClO2 (1.51 g, 13.8 mmol) and NaH2PO4·H2O (0.96 g, 6.94 mmol) in water (20 mL).</text></s> <s sid="135"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>The mixture was stirred for one hour and the solvent was removed under vacuum.</text></s> <s sid="136"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>The residue was dissolved in 2 M NaOH, acidified with 1 M HCl, and the precipitate was filtered off and dried giving <XREF ID="chem8a" TYPE="COMPOUND">8a</XREF> as a slightly yellow solid (593 mg, 99percent) which was used without further purification for the macrocyclization step; δH (acetone-d6) 2.43 (4H, t, J 6.5, 2 × –CH2COOH), 4.16–4.36 (4H, m, 2 × –CH2O–), 7.01–7.32 (6H, m, ArH), 7.54 (2H, d, J 9.0, ArH), 7.86 (2H, br d, J 7.9, ArH), 7.96 (2H, d, J 9.0, ArH), 9.0 (2H, br s, 2 × –COOH); δC (acetone-d6) 35.9, 67.0, 117.5, 121.9, 125.2, 126.9, 127.8, 129.7, 131.1, 131.2, 135.7, 156.0, 174.2; HR-MS (ES) calc.</text></s> <s sid="137"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>C26H22O6Na (M + Na): 453.1314, found 453.1309.</text></s></P></DIV><DIV DEPTH="2"><HEADER>(R)-2,2′-Bis(3-carboxypropoxy)-1,1-binaphthyl (<XREF ID="chem8b" TYPE="COMPOUND">8b</XREF>)</HEADER><P><s sid="138"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/><text>A mixture of (R)-BINOL (572 mg, 2.00 mmol), ethyl 4-bromobutyrate (1.25 g, 6.0 mmol) and K2CO3 (1.12 g, 8.0 mmol) was refluxed in dry acetone (25 mL) for two days.</text></s> <s sid="139"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/><text>The solvent was removed under vacuum, and the residue was partitioned between CH2Cl2 and water.</text></s> <s sid="140"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/><text>The organic layer was separated, dried with Mg2SO4 and evaporated to dryness.</text></s> <s sid="141"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/><text>Purification by flash chromatography (pentane ∶ ethyl acetate, 7 ∶ 1) gave a quantitative yield of the diethyl ester of <XREF ID="chem8b" TYPE="COMPOUND">8b</XREF>.</text></s></P><P><s sid="142"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/><text>The diester was redissolved in a 1 ∶ 1 mixture of 2 M NaOH and EtOH (20 mL) and refluxed overnight followed by removal of the solvent under vacuum.</text></s> <s sid="143"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/><text>The residue was dissolved in water, which was then acidified with 1 M HCl.</text></s> <s sid="144"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/><text>The precipitate formed was filtered off and triturated with acetone to give <XREF ID="chem8b" TYPE="COMPOUND">8b</XREF> as an off-white solid (809 mg, 88percent); [α]25D = +55.6 (c = 1.0, THF); δH (acetone-d6) 1.59–1.75 (4H, m, 2 × –CH2–), 1.92–2.04 (4H, m, 2 × –CH2COOH), 3.96–4.14 (4H, m, 2 × –CH2O–), 7.01–7.32 (6H, m, ArH), 7.53 (2H, d, J 9.0, ArH), 7.87 (2H, br d, J 7.9, ArH), 7.98 (2H, d, J 9.0, ArH); δC (acetone-d6) 26.4, 31.1, 69.8, 117.1, 121.8, 125.2, 126.8, 127.9, 129.8, 131.1 (2C), 135.8, 156.0, 175.9; HR-MS (ES) calc.</text></s> <s sid="145"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/><text>C28H26O6Na (M + Na): 481.1627, found 481.1622; IR (KBr) 2939, 1706, 1263 cm–1.</text></s></P></DIV><DIV DEPTH="2"><HEADER>(R)-2,2′-Bis(4-carboxybutoxy)-1,1′-binaphthyl (<XREF ID="chem8c" TYPE="COMPOUND">8c</XREF>)</HEADER><P><s sid="146"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/><text>In a procedure similar to that of <XREF ID="chem8b" TYPE="COMPOUND">8b</XREF>, (R)-BINOL (1.14 g, 4.00 mmol), ethyl 5-bromovalerate (2.34 g, 12.0 mmol) and K2CO3 (2.21 g, 16.0 mmol) gave the diethyl ester of <XREF ID="chem8c" TYPE="COMPOUND">8c</XREF>, which was hydrolyzed and then recrystallized from acetone to give <XREF ID="chem8c" TYPE="COMPOUND">8c</XREF> as colorless crystals (1.63 g, 84percent); <datasection id="o1659" type="dataSection">mp = 156–157 °C; [α]25D = +47.1 (c = 1.0, THF); δH (acetone-d6) 1.24–1.56 (8H, m, 4 × –CH2–), 2.02 (4H, t, J 7.3, 2 × –CH2COOH), 3.96–4.14 (4H, m, 2 × –CH2O–), 7.06 (2H, br d, J 8.1, ArH), 7.16–7.35 (4H, m, ArH), 7.55 (2H, d, J 8.8, ArH), 7.90 (2H, br d, J 7.3, ArH), 8.01 (2H, d, J 8.8, ArH), 10.3 (2H, br s, ArH); δC (DMSO-d6) 20.6, 28.1, 32.9, 68.0, 115.3, 119.0, 123.1, 124.4, 126.0, 127.8, 128.6, 129.0, 133.3, 153.7, 174.1; HR-MS (ES) calc. for C30H30O6Na (M + Na): 509.1940, found 509.1937; IR (KBr) 2927, 1706, 1230 cm–1.</datasection></text></s></P></DIV><DIV DEPTH="2"><HEADER>(R)-3,3′-Di-2-naphthyl-2,2′-bis(4-carboxybutoxy)-1,1′-binaphthyl (<XREF ID="chem9" TYPE="COMPOUND">9</XREF>)</HEADER><P><s sid="147"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>A mixture of (R)-3,3′-di-2-naphthyl-BINOL (140 mg, 0.26 mmol), ethyl 5-bromovalerate (209 mg, 1.00 mmol) and K2CO3 (138 mg, 1.00 mmol) was refluxed in dry acetone (4 mL) overnight.</text></s> <s sid="148"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>The mixture was partitioned between CH2Cl2 and water, and the organic layer was separated and dried with Mg2SO4 followed by evaporation to dryness.</text></s> <s sid="149"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>Purification by flash chromatography (pentane ∶ ethyl acetate, 10 ∶ 1) gave the functionalized ester of <XREF ID="chem9" TYPE="COMPOUND">9</XREF> (177 mg, 86percent) as a colorless oil, which was hydrolyzed by refluxing overnight in a 1 ∶ 1 mixture of 2 M NaOH and EtOH (8 mL).</text></s> <s sid="150"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>The solvent was removed under vacuum and the residue was redissolved in water.</text></s> <s sid="151"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>After acidification with 1 M HCl and extraction with EtOAc (2×), the combined organic layers were dried with Mg2SO4 and evaporated to dryness.</text></s> <s sid="152"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>The residue was purified by flash chromatography (CH2Cl2 ∶ acetone, 10 ∶ 1) to give <XREF ID="chem9" TYPE="COMPOUND">9</XREF> as a colorless oil (107 mg, 56percent overall); δH (CDCl3) 0.80–1.19 (8H, m, 4 × –CH2–), 1.65 (4H, t, J 6.8, 2 × –CH2COOH), 3.15–3.29 (2H, m, 2 × –CHH′O–), 3.43–3.57 (2H, m, 2 × –CHH′O), 7.22–7.53 (10H, m, ArH), 7.83–8.01 (10H, m, ArH), 8.10 (2H, s, ArH), 8.53 (2H, s, ArH), 10.5 (2H, br s, 2 × –COOH); δC (CDCl3) 20.5, 28.8, 32.9, 71.9, 124.9, 125.8, 125.9, 126.0, 126.2, 127.4, 127.5, 127.7, 127.8, 128.1, 130.6, 130.8, 132.5, 133.4, 133.6, 135.2, 136.5, 153.4, 179.6; HR-MS (ES) calc.</text></s> <s sid="153"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>C50H42O6Na (M + Na): 761.2879, found 761.2891.</text></s></P></DIV><DIV DEPTH="2"><HEADER>General procedure for the macrocyclizations of the BINOL-diacids with diamine <XREF ID="chem10" TYPE="COMPOUND">10</XREF></HEADER><P><s sid="154"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>The diacid (typically 1 mmol) was converted into the diacid dichloride by stirring with oxalyl dichloride (10 eq.) and DMF (one drop) in CH2Cl2 (40 mL) for 1 to 3 hours.</text></s> <s sid="155"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>The solvent was removed under vacuum, and the diacid dichloride obtained was dried under vacuum for at least 1 h.</text></s> <s sid="156"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>The crude diacid dichloride, redissolved in THF (20 mL), and the diamine <XREF ID="chem10" TYPE="COMPOUND">10</XREF> (1.0 eq.) and triethylamine (1.2 eq.) in THF (20 mL) were separately added dropwise simultaneously to a flask with THF (100 mL) over 1–3 h.</text></s> <s sid="157"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>After stirring overnight, the solvent was removed under vacuum and the residue was partitioned between CH2Cl2 and water.</text></s> <s sid="158"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>The organic layer was dried with Mg2SO4 and the residue obtained after evaporation to dryness was purified by flash chromatography to give the macrocycles.</text></s></P><DIV DEPTH="3"><HEADER>Macrocycle <XREF ID="chem3a" TYPE="COMPOUND">3a</XREF></HEADER><P><s sid="159"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>The diacid <XREF ID="chem8a" TYPE="COMPOUND">8a</XREF> (593 mg, 1.38 mmol) subjected to the above macrocyclization procedure gave after flash chromatography (CH2Cl2 ∶ acetone, 15 ∶ 1 to 10 ∶ 1) 370 mg (36percent) of <XREF ID="chem3a" TYPE="COMPOUND">3a</XREF> as a white solid; <datasection id="o1661" type="dataSection">[α]25D = +276 (c = 1.0, THF); δH (CDCl3) 2.62–3.04 (4H, m, 2 × –CH2CO–), 4.00–4.32 (4H, m, 2 × –CH2O–), 6.80–7.25 (6H, m, ArH), 7.40–7.56 (4H, m, ArH), 7.68–8.05 (9H, m, ArH), 8.25–8.38 (4H, m, ArH), 8.49 (2H, br s, 2 × –CONH–), 9.33 (2H, br s, 2 × –CONH–); δC (CDCl3) 37.4, 67.3, 110.1, 111.0, 117.3, 121.5, 124.8, 125.0, 125.2, 127.0, 127.8, 130.0, 130.3, 130.8, 132.6, 133.9, 134.0, 140.1, 148.2, 149.9, 153.2, 164.9, 170.5; HR-MS (ES) calc. for C44H34N6O6Na (M + Na): 765.2438, found 765.2440; IR (KBr) 3386, 1684, 1534, 1450 cm–1.</datasection></text></s></P></DIV><DIV DEPTH="3"><HEADER>Macrocycle <XREF ID="chem3b" TYPE="COMPOUND">3b</XREF></HEADER><P><s sid="160"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/><text>The diacid <XREF ID="chem8b" TYPE="COMPOUND">8b</XREF> (252 mg, 0.55 mmol) subjected to the above macrocyclization procedure gave after flash chromatography (CH2Cl2 ∶ acetone, 10 ∶ 1) 216 mg (56percent) of <XREF ID="chem3b" TYPE="COMPOUND">3b</XREF> as a white solid; <datasection id="o1662" type="dataSection">[α]25D = +259 (c = 1.0, THF); δH (CDCl3) 3.70–3.84 (2H, m, 2 × –CHH′O–), 4.10–3.95 (2H, m, 2 × –CHH′O–), 7.09–7.38 (6H, m, ArH), 7.40–7.50 (2H, m, ArH), 7.66–7.86 (9H, m, ArH), 7.91–8.00 (2H, m, ArH), 8.07–8.16 (2H, m, ArH), 8.29–8.36 (3H, m, ArH and 2 × –CONH–), 8.95 (2H, br s, 2 × –CONH–); δC 25.3, 33.5, 69.8, 109.6, 110.0, 117.4, 121.6, 123.7, 124.2, 125.2, 126.5, 127.9, 129.6, 129.7, 129.9, 132.8, 133.7, 133.9, 140.8, 149.3, 149.7, 154.3, 164.4, 171.2; HR-MS (ES) calc. for C46H38N6O6Na (M + Na): 793.2751, found 793.2750; IR (KBr) 3386, 1686, 1586, 1452 cm–1.</datasection></text></s></P></DIV><DIV DEPTH="3"><HEADER>Macrocycle <XREF ID="chem3c" TYPE="COMPOUND">3c</XREF></HEADER><P><s sid="161"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/><text>The diacid <XREF ID="chem8c" TYPE="COMPOUND">8c</XREF> (973 mg, 2.0 mmol) subjected to the above macrocyclization procedure gave after flash chromatography (CH2Cl2 ∶ acetone, 10 ∶ 1) 910 mg (57percent) of <XREF ID="chem3c" TYPE="COMPOUND">3c</XREF> as a white solid; <datasection id="o1663" type="dataSection">[α]25D = +121 (c = 1.0, THF); δH (CDCl3) 1.18–1.60 (8H, m, 2 × –CH2–), 1.80–1.94 (4H, m, 2 × –CH2CO–), 3.91–4.02 (4H, m, 2 × –CH2O–), 7.12–7.37 (6H, m, ArH), 7.43–7.52 (2H, m, ArH), 7.67–7.85 (9H, m, ArH), 7.91–7.99 (2H, m, ArH), 8.06–8.13 (2H, m, ArH), 8.22–8.37 (3H, m, ArH and 2 × –CONH–), 8.78 (2H, br s, 2 × –CONH–); δC (CDCl3) 22.5, 28.9, 37.3, 70.6, 110.3, 110.3, 110.7, 117.1, 123.4, 124.7, 124.9, 126.0, 127.1, 128.5, 130.2, 130.3, 130.9, 133.6, 134.8, 134.8, 150.3, 150.3, 155.0, 164.9, 172.1; HR-MS (ES) calc. for C48H42N6O6Na (M + Na): 821.3064, found 821.3065; IR (KBr) 3390, 1686, 1585, 1451 cm–1.</datasection></text></s></P></DIV><DIV DEPTH="3"><HEADER>Macrocycle <XREF ID="chem4" TYPE="COMPOUND">4</XREF></HEADER><P><s sid="162"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp17" novelty="None" advantage="None"/><text>The diacid <XREF ID="chem9" TYPE="COMPOUND">9</XREF> (177 mg, 0.22 mmol) subjected to the above macrocyclization procedure gave after flash chromatography (CH2Cl2 ∶ acetone, 25 ∶ 1) 115 mg (50percent) of <XREF ID="chem4" TYPE="COMPOUND">4</XREF> as a white solid; <datasection id="o1664" type="dataSection">[α]25D = –248 (c = 0.5, THF); δH (CDCl3) 0.83–1.18 (8H, m, 2 × –CH2–), 1.67–1.88 (4H, m, 2 × –CH2CO–), 3.16–3.33 (2H, m, 2 × –CHH′O–), 3.41–3.54 (2H, m, 2 × –CHH′O–), 7.12–8.26 (36H, m, ArH and 2 × –CONH–), 8.68 (2H, br s, 2 × –CONH–); δC (CDCl3) 22.0, 28.9, 37.2, 72.2, 109.3, 109.9, 125.2, 128.3–125.7 (multiple peaks), 128.9, 130.2, 130.7, 130.8, 132.4, 132.8, 133.3, 133.6, 134.0, 134.7, 136.3, 140.7, 149.2, 149.4, 153.3, 164.2, 171.1; HR-MS (ES) calc. for C68H54N6O6Na (M + Na): 1073.4003, found 1073.3994.</datasection></text></s></P></DIV></DIV><DIV DEPTH="2"><HEADER>(3α,12α-Dihydroxy-5β-cholan-24-yloxy)triphenylmethane (<XREF ID="chem11" TYPE="COMPOUND">11</XREF>)</HEADER><P><s sid="163"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/><text>LiAlH4 (150 mg, 3.87 mmol) was added with caution to a solution of methyl deoxycholate (1.05 g, 2.58 mmol) in THF (25 mL).</text></s> <s sid="164"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/><text>The reaction mixture was refluxed for 40 h and then carefully quenched with saturated Na2SO4 (10 mL).</text></s> <s sid="165"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/><text>The resulting precipitate was filtered off and washed with hot THF and MeOH.</text></s> <s sid="166"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/><text>The combined filtrate was dried over MgSO4 and the solvent was removed under vacuum affording 5β-cholan-3α,12α,24-triol as colorless crystals (0.935 g, 96percent); mp = 115 °C (lit.</text></s> <s sid="167"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs17" novelty="None" advantage="None"/><text>122–124 °C);<REF ID="R-69" REFID="cit32"/> δH (CDCl3) 0.68 (3H, s, –CH3), 0.91 (3H, s, –CH3), 0.98 (3H, d, J 6.6, –CHCH3), 1.01–1.95 (28H, m, cholan–CH and CH2's), 3.52–3.70 (3H, m, –CH2OH and cholan–CH), 3.99 (1H, m, cholan–CH); δC (DMSO-d6) 12.5, 14.2, 17.4, 23.1, 23.6, 25.2, 26.2, 27.1, 27.4, 28.7, 29.4, 30.3, 32.0, 33.9, 35.4, 35.8, 36.3, 41.7, 46.0, 46.4, 47.5, 67.1, 70.0, 71.1; HR-MS (ES) calc. for C24H42O3Na (M + Na): 401.3032, found 401.3026; IR (KBr) 3363, 2938, 1044 cm–1.</text></s></P><P><s sid="168"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/><text>The above triol (0.88 g, 2.33 mmol) was subjected to trityl chloride (0.91 g, 3.26 mmol), DMAP (5 mg), and triethylamine (0.7 mL, 5.0 mmol) in DMF (12 mL) and then stirred for 3 days at 50 °C.</text></s> <s sid="169"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/><text>Water and ethyl acetate were added to the reaction mixture, and the aqueous phase was extracted three times with ethyl acetate.</text></s> <s sid="170"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/><text>The combined organic phases were washed with water and brine.</text></s> <s sid="171"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/><text>After drying with MgSO4 and evaporation to dryness, flash chromatography (pentane ∶ ethyl acetate, 2 ∶ 1) afforded <XREF ID="chem11" TYPE="COMPOUND">11</XREF> as a white solid (1.02 g, 70percent); <datasection id="o1666" type="dataSection">δH (CDCl3) 0.66 (3H, s, –CH3), 0.91 (3H, s, CH3), 0.95 (3H, d, J 6.3, –CHCH3), 0.98–1.94 (28H, m, cholan–CH and CH2's), 2.97–3.07 (2H, m, –CH2OTr), 3.60 (1H, m, cholan–CH), 3.98 (1H, m, cholan–CH), 7.16–7.34 (9H, m, 9 × trityl-H), 7.40–7.48 (6H, m, 6 × trityl-H); δC (CDCl3) 13.0, 14.2, 17.9, 23.4, 23.9, 26.4, 26.8, 27.3, 27.7, 28.7, 30.7, 32.4, 33.9, 34.3, 35.5, 36.3, 36.6, 42.3, 46.7, 47.8, 48.5, 64.3, 72.0, 73.5, 86.5, 127.9 (3C), 128 (6C), 128.9 (6C), 144.7 (3C); HR-MS (ES) calc. for C43H56O3Na (M + Na): 643.4127, found 643.4214; IR (KBr) 3410, 2936, 1448, 705 cm–1.</datasection></text></s></P></DIV><DIV DEPTH="2"><HEADER>3α,12α-Bis(3′-hydroxypropoxy)-5β-cholan-24-oxytriphenylmethane (<XREF ID="chem12" TYPE="COMPOUND">12</XREF>)</HEADER><P><s sid="172"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/><text>NaH (60percent in mineral oil, 0.20 g, 5.0 mmol) was carefully added to a solution of <XREF ID="chem11" TYPE="COMPOUND">11</XREF> (1.01 g, 1.63 mmol) in THF (20 mL), whereafter the reaction mixture was refluxed for 30 minutes.</text></s> <s sid="173"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/><text>Allyl bromide (2.0 mL, 16 mmol) was then added and refluxing was continued for another 48 h.</text></s> <s sid="174"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/><text>As TLC analysis revealed that the reaction was not complete, an additional portion of NaH (0.33 g, 8.2 mmol) and allyl bromide (2.0 mL, 16 mmol) was added.</text></s> <s sid="175"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/><text>After refluxing for 40 h, the reaction mixture was cooled to 20 °C, and the excess NaH was destroyed with H2O.</text></s> <s sid="176"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/><text>After neutralization with 1 M HCl, the mixture was extracted with ether, and the organic phase was washed with water and brine, and then dried over MgSO4.</text></s> <s sid="177"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/><text>The residue obtained after evaporation under vacuum was purified by flash chromatography (pentane ∶ ethyl acetate, 125 ∶ 1) yielding a yellow solid (0.92 g, 80percent); <datasection id="o1667" type="dataSection">δH (CDCl3) 0.64 (3H, s, –CH3), 0.82–2.03 (32H, m, cholan–CH, –CH2 and –CH3's), 3.01 (2H, m, –CH2OTr), 3.29 (1H, m, cholan–OCH), 3.54 (1H, m, cholan–OCH), 3.75 (1H, ddt, J 12.6, 5.4, 1.5, –CHH′O–), 4.00 (2H, dt, J 5.5, 1.4, –CH2O–), 4.05 (1H, ddt, J 12.6, 5.4, 1.3, –CHH′O–), 5.07–5.18 (2H, m, 2 × allyl-H), 5.20–5.35 (2H, m, 2 × allyl-H), 5.82–6.04 (2H, m, 2 × allyl-H), 7.16–7.33 (9H, m, 9 × trityl-H), 7.40–7.48 (6H, m, 6 × trityl-H); δC (CDCl3) 13.0, 18.0, 23.4, 23.6, 23.9, 26.3, 26.8, 27.6, 27.7, 27.8, 32.5, 33.3, 33.9, 34.8, 35.7, 36.3, 42.5, 46.6, 46.8, 49.0, 64.4, 69.0, 69.6, 78.9, 81.3, 86.4, 116.0, 116.6, 127.0, 127.9, 128.9, 135.8, 136.0, 144.8 (3C); HR-MS (ES) calc. for C49H64O3Na (M + Na): 723.4753, found 723.4749; IR (KBr) 2938, 1449, 1075, 706 cm–1.</datasection></text></s></P><P><s sid="178"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/><text>9-BBN (17 mL, 8.5 mmol, 0.5 M in THF) was added dropwise to the above diallylated compound (1.87 g, 2.67 mmol) in THF (30 mL) at 0 °C, under N2 and the solution was stirred for 2 h at 20 °C.</text></s> <s sid="179"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/><text>After cooling down to 0 °C, 35percent aqueous H2O2 (3.8 mL) and 33percent aqueous NaOH (4.1 mL) were carefully added.</text></s> <s sid="180"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/><text>The reaction mixture was stirred overnight and then diluted with 100 mL of brine.</text></s> <s sid="181"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/><text>The aqueous phase was extracted twice with ethyl acetate, whereafter the combined organic phases were dried over Na2SO4.</text></s> <s sid="182"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/><text>After evaporation to dryness, the residue obtained was purified by flash chromatography (pentane ∶ ethyl acetate, 1 ∶ 1) affording the diol <XREF ID="chem12" TYPE="COMPOUND">12</XREF> as a white solid (1.48 g, 75percent); <datasection id="o1668" type="dataSection">δH (CDCl3) 0.64 (3H, s, –CH3), 0.82–1.95 (36H, m, cholan–CH, –CH2 and –CH3's and 2 × propoxy–CH2–), 2.95–3.07 (4H, m, –CH2OTr and 2 × OH), 3.18–3.37 (2H, m, cholan–OCH and –CHH′O–), 3.50 (1H, m, cholan–OCH), 3.62–3.84 (7H, m, 2 × CH2OH, –CH2O– and –CHH′O–), 7.16–7.34 (9H, m, 9 × trityl–H), 7.40–7.47 (6H, m, 6 × trityl–H); δC (CDCl3) 13.0, 18.2, 22.7, 23.4, 23.9, 26.3, 26.8, 27.2, 27.4, 27.7, 32.2, 32.5, 32.7, 33.3, 33.8, 34.6, 35.4, 35.5, 36.1, 42.2, 46.4, 47.1, 49.2, 62.0, 62.8, 64.3, 66.7, 67.6, 79.5, 81.4, 86.4, 126.9, 127.8, 128.9, 144.7; HR-MS (ES) calc. for C49H68O5Na (M + Na): 759.4965, found 759.4968.</datasection></text></s></P></DIV><DIV DEPTH="2"><HEADER>Macrocycle <XREF ID="chem5" TYPE="COMPOUND">5</XREF></HEADER><P><s sid="183"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/><text>Phosgene (1.1 mL, 1.54 mmol, 1.4 M in toluene) was added to a solution of <XREF ID="chem10" TYPE="COMPOUND">10</XREF> (211 mg, 0.61 mmol) in THF (10 mL) at 0 °C.</text></s> <s sid="184"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/><text>After stirring for 15 min at 20 °C, Et3N (0.38 mL, 2.8 mmol) was added to the suspension.</text></s> <s sid="185"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/><text>Stirring was continued at this temperature for an additional 15 min, afterwhich the reaction mixture was heated to reflux.</text></s> <s sid="186"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/><text>Methyl deoxycholate (0.25 g, 0.61 mmol) in THF (10 mL) was added over a period of 30 hours.</text></s> <s sid="187"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/><text>After completed addition, the reaction mixture was refluxed for an additional 48 hours.</text></s> <s sid="188"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/><text>The solvent was removed under vacuum and the residue was redissolved in CH2Cl2 and H2O, and filtered through Celite.</text></s> <s sid="189"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/><text>The organic phase was washed with water and dried over MgSO4.</text></s> <s sid="190"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs18" novelty="None" advantage="None"/><text>The pure product (57 mg, 12percent) was obtained as a colorless solid by flash chromatography (CH2Cl2 ∶ acetone, 50 ∶ 1); [α]25 D = +66 (c = 0.8, THF); <datasection id="o1669" type="dataSection">δH (CDCl3) 0.76 (3H, s, –CH3), 0.89 (3H, d, J 5.4, –CHCH3), 0.94 (3H, s, –CH3), 0.98–2.53 (26H, m, cholan–CH and CH2's), 3.67 (3H, s, –OCH3), 4.63 (1H, m, cholan–OCH), 5.26 (1H, m, cholan–OCH), 7.07–7.37 (3H, m, ArH), 7.57–7.87 (5H, m, ArH), 7.96 (1H, d, J 8.0, ArH), 8.13 (1H, d, J 8.0, ArH), 8.20–8.29 (2H, m, 2 × –OCONH–), 8.90 (1H, br s, –CONH–), 9.10 (1H, br s, –CONH–); HR-MS (ES) calc. for C45H54N6O8Na (M + Na) 829.3901, found 829.3903; IR (KBr) 3409, 2948, 1740, 1585, 1455, 1210 cm–1.</datasection></text></s></P></DIV><DIV DEPTH="2"><HEADER>Macrocycle <XREF ID="chem6" TYPE="COMPOUND">6</XREF></HEADER><P><s sid="191"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp21" novelty="None" advantage="None"/><text>Phosgene (0.72 mL, 1.0 mmol, 1.4 M in toluene) was added to a solution of <XREF ID="chem10" TYPE="COMPOUND">10</XREF> (150 mg, 0.43 mmol) in THF (15 mL) at 0 °C.</text></s> <s sid="192"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp21" novelty="None" advantage="None"/><text>The colorless suspension obtained was stirred for 15 min at 20 °C, followed by the addition of Et3N (0.26 mL, 1.9 mmol).</text></s> <s sid="193"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp21" novelty="None" advantage="None"/><text>The reaction mixture was stirred at 20 °C for an additional 15 min, and then a solution of <XREF ID="chem12" TYPE="COMPOUND">12</XREF> (317 mg, 0.43 mmol) in THF (15 mL) was added over a period of 2 hours.</text></s> <s sid="194"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp21" novelty="None" advantage="None"/><text>After stirring for 1 h, the solvent was removed under vacuum, and the residue was redissolved in CH2Cl2 and washed with H2O and dried with MgSO4.</text></s> <s sid="195"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs19" novelty="None" advantage="None"/><text>After evaporation to dryness, the pure macrocycle <XREF ID="chem6" TYPE="COMPOUND">6</XREF> (72 mg, 15percent) was obtained as a colorless solid by flash chromatography (CH2Cl2 ∶ acetone, 30 ∶ 1); <datasection id="o1670" type="dataSection">[α]25D = +5.0 (c = 0.5, THF); δH (acetone-d6) 0.69 (3H, m, –CH3), 0.88–2.05 (36H, m, cholan–CH, CH2 and CH3's and 2 × propoxy–CH2), 3.06 (2H, m, –CH2OTr), 3.23–3.40 (2H, m, cholan–OCH and –CHH′O–), 3.49–3.79 (4H, m, cholan–OCH–, –CHH′O– and –CH2O–), 4.19–4.37 (4H, m, 4 × –CH2OCONH–), 7.18–7.28 (9H, m, 9 × trityl-H), 7.42–7.51 (6H, m, 6 × trityl-H), 7.60–7.87 (7H, m, ArH and 2 × –OCONH–), 8.04–8.11 (2H, m, ArH), 8.19–8.27 (2H, m, ArH), 8.56 (1H, d, J 8.7, ArH), 8.75 (1H, br s, –CONH–), 9.99 (1H, br s, –CONH–); HR-MS (ES) calc. for C69H80N6O9Na (M + Na) 1159.5885, found 1159.5804; IR (KBr) 3406, 2938, 1740, 1687, 1583, 1453, 1304, 1210 cm–1.</datasection></text></s></P></DIV><DIV DEPTH="2"><HEADER>5-Hydroxymethyl-5-isopropylbarbituric acid (<XREF ID="chem16a" TYPE="COMPOUND">16a</XREF>)<REF ID="R-70" REFID="cit20"/></HEADER><P><s sid="196"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp22" novelty="None" advantage="None"/><text>5-Isopropylbarbituric acid (3.40 g, 20 mmol), formaldehyde (1.7 mL, 23 mmol, 35percent in H2O) and 2 drops of conc. HCl were mixed in water (10 mL) and refluxed until the barbiturate had completely dissolved (approx.</text></s> <s sid="197"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp22" novelty="None" advantage="None"/><text>1 h).</text></s> <s sid="198"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp22" novelty="None" advantage="None"/><text>After cooling in an ice bath for several hours, the colorless crystals of <XREF ID="chem16a" TYPE="COMPOUND">16a</XREF> were filtered off (3.80 g, 95percent); <datasection id="o1671" type="dataSection">mp = 185–187 °C; δH (DMSO-d6) 0.88 (6H, d, J 6.9, 2 × isopropyl–CH3), 2.19 (1H, sept, J 6.9, isopropyl–CH), 3.82 (2H, s, –CH2–), 11.41 (2H, br s, 2 × NH); HR-MS (ES) calc. for C8H12N2O4Na (M + Na) 223.0695, found 223.0650; IR (KBr) 3481, 3259, 1762, 1716, 1690 cm–1.</datasection></text></s></P></DIV><DIV DEPTH="2"><HEADER>5-Hydroxymethyl-5-methylbarbituric acid (<XREF ID="chem16b" TYPE="COMPOUND">16b</XREF>)</HEADER><P><s sid="199"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp23" novelty="None" advantage="None"/><text>Employing a similar procedure as described for the preparation of <XREF ID="chem16a" TYPE="COMPOUND">16a</XREF>, 5-methylbarbituric acid (1.15 g, 8.1 mmol) was converted into <XREF ID="chem16b" TYPE="COMPOUND">16b</XREF> (299 mg, 22percent); <datasection id="o1672" type="dataSection">δH (DMSO-d6) 1.20 (3H, s, –CH3), 3.63 (2H, d, J 5.0, –CH2–), 5.51 (1H, t, J 5.0, –OH), 11.2 (2H, br s, 2 × NH); IR (KBr) 3240, 1717, 1168 cm–1.</datasection></text></s></P></DIV><DIV DEPTH="2"><HEADER>5-Hydroxymethyl-5-phenylbarbituric acid (<XREF ID="chem16c" TYPE="COMPOUND">16c</XREF>)</HEADER><P><s sid="200"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp24" novelty="None" advantage="None"/><text>Employing a similar procedure as described for the preparation of <XREF ID="chem16a" TYPE="COMPOUND">16a</XREF>, 5-phenylbarbituric acid (2.04 g, 10 mmol) was converted into <XREF ID="chem16c" TYPE="COMPOUND">16c</XREF> (1.90 g, 81percent); <datasection id="o1673" type="dataSection">mp = 181–182 °C; δH (acetone-d6) 4.46 (2H, d, J 5.0, –CH2–), 4.72 (1H, t, J 5.0, –OH), 7.36–7.42 (5H, m, 5 × phenyl-H), 10.45 (2H, br s); HR-MS (ES) calc. for C11H10N2O4Na (M + Na) 257.0539, found 257.0538; IR (KBr) 3255, 1760, 1714 cm–1.</datasection></text></s></P></DIV><DIV DEPTH="2"><HEADER>5-Cinnamoyloxymethyl-5-isopropylbarbituric acid (<XREF ID="chem17a" TYPE="COMPOUND">17a</XREF>)</HEADER><P><s sid="201"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp25" novelty="None" advantage="None"/><text>Barbiturate <XREF ID="chem16a" TYPE="COMPOUND">16a</XREF> (0.80 g, 4.0 mmol) was refluxed in THF (20 mL) with cinnamoyl chloride (2.67 g, 16.0 mmol) for 2 days.</text></s> <s sid="202"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp25" novelty="None" advantage="None"/><text>After evaporation to dryness, the residue was purified by flash chromatography (pentane ∶ ethyl acetate, 4 ∶ 1) followed by recrystallization in ethyl acetate–pentane to give <XREF ID="chem17a" TYPE="COMPOUND">17a</XREF> as colorless crystals (1.08 g, 82percent); <datasection id="o1674" type="dataSection">mp = 201–202 °C; δH (acetone-d6) 1.06 (6H, d, J 7.0, 2 × isopropyl–CH3), 2.42 (1H, sept, J 7.0, isopropyl–CH), 4.62 (2H, s, –CH2–), 6.38 (1H, d, J 16.0, alkene-H), 7.31–7.40 (3H, m, 3 × phenyl-H), 7.49–7.62 (3H, m, 2 × phenyl-H and alkene-H), 10.39 (2H, br s, 2 × NH); HR-MS (ES) calc. for C17H18N2O5Na (M + Na) 353.1114, found 353.1112; IR (KBr) 3094, 1764, 1717, 1686, 1643 cm–1.</datasection></text></s></P></DIV><DIV DEPTH="2"><HEADER>5-Cinnamoyloxymethyl-5-methylbarbituric acid (<XREF ID="chem17b" TYPE="COMPOUND">17b</XREF>)</HEADER><P><s sid="203"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp26" novelty="None" advantage="None"/><text>Employing a similar procedure as described for the synthesis of <XREF ID="chem17a" TYPE="COMPOUND">17a</XREF>, <XREF ID="chem16b" TYPE="COMPOUND">16b</XREF> (290 mg, 1.64 mmol) was converted into <XREF ID="chem17b" TYPE="COMPOUND">17b</XREF> (447 mg, 90percent); <datasection id="o1675" type="dataSection">mp = 186–187 °C; δH (CDCl3) 1.61 (3H, s, –CH3), 4.59 (2H, s, –CH2–), 6.33 (1H, d, J 16.0, alkene-H), 7.36–7.42 (3H, m, 3 × phenyl-H), 7.47–7.54 (2H, m, 2 × phenyl-H), 7.64 (1H, d, J 16.0, alkene-H), 7.98 (2H, br s); HR-MS (ES) calc. for C15H14N2O5Na (M + Na) 325.0801, found 325.0801; IR (KBr) 3243, 1710, 1640 cm–1.</datasection></text></s></P></DIV><DIV DEPTH="2"><HEADER>5-Cinnamoyloxymethyl-5-phenylbarbituric acid (<XREF ID="chem17c" TYPE="COMPOUND">17c</XREF>)</HEADER><P><s sid="204"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp27" novelty="None" advantage="None"/><text>Employing a similar procedure as described for the synthesis of <XREF ID="chem17a" TYPE="COMPOUND">17a</XREF>, <XREF ID="chem16c" TYPE="COMPOUND">16c</XREF> (234 mg, 1.0 mmol) was converted into <XREF ID="chem17c" TYPE="COMPOUND">17c</XREF> (317 mg, 87percent); <datasection id="o1676" type="dataSection">mp = 198–199 °C; δH (CDCl3) 4.98 (2H, s, –CH2–), 6.38 (1H, d, J 16.0, alkene-H), 7.36–7.44 (8H, m, 8 × phenyl-H), 7.48–7.55 (2H, m, 2 × phenyl-H), 7.68 (1H, d, J 16.0, alkene-H), 8.07 (2H, br s, NH); HR-MS (ES) calc. for C20H16N2O5Na (M + Na) 387.0957, found 387.0962; IR (KBr) 3095, 1764, 1718, 1687, 1642 cm–1.</datasection></text></s></P></DIV><DIV DEPTH="2"><HEADER>General procedure for the nitrile oxide cycloadditions</HEADER><P><s sid="205"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp28" novelty="None" advantage="None"/><text>The cinnamoyl derivative (0.1 mmol) and the chiral host (0.12–0.14 mmol) were dissolved in CH2Cl2 (1 mL).</text></s> <s sid="206"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp28" novelty="None" advantage="None"/><text>A solution of the chlorooxime (0.12 mmol) in CH2Cl2 (1 mL) was added followed by triethylamine (0.12 mmol), and the reaction mixture was stirred overnight at 20 °C.</text></s> <s sid="207"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp28" novelty="None" advantage="None"/><text>The solvent was removed under vacuum and the residue was purified by flash chromatography (CH2Cl2 ∶ acetone, 40 ∶ 1 to 6 ∶ 1) affording a mixture of the regioisomeric cycloaddition adducts <XREF ID="chem18" TYPE="COMPOUND">18</XREF> and <XREF ID="chem19" TYPE="COMPOUND">19</XREF> as white solids, the unreacted cinnamate <XREF ID="chem17" TYPE="COMPOUND">17</XREF>, and the recovered chiral host.</text></s></P><DIV DEPTH="3"><HEADER>Cycloaddition adducts <XREF ID="chem18a" TYPE="COMPOUND">18a</XREF> and <XREF ID="chem19a" TYPE="COMPOUND">19a</XREF></HEADER><P><s sid="208"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs20" novelty="None" advantage="None"/><text><datasection id="o1677" type="dataSection">Mixture of regioisomers; δH (CDCl3) 1.00 (6H18a, d, J 6.9, 2 × isopropyl–CH3), 1.06 (3H19a, d, J 6.9, isopropyl–CH3), 1.07 (3H19a, d, J 6.9, isopropyl–CH3), 2.33 (1H18a + 1H19a, sept, J 6.9, 2 × isopropyl–CH), 4.39 (1H18a, d, J 5.4, 4-H), 4.59 (1H18a, d, J 10.1, –CHH′–), 4.66 (1H19a, d, J 10.0, –CHH′–), 4.71 (1H18a, d, J 10.1, –CHH′–), 4.76 (1H19a, d, J 10.0, –CHH′–), 4.87 (1H19a, d, J 4.1, isoxazoline-H), 4.90 (1H19a, d, J 4.1, isoxazoline-H), 5.90 (1H18a, d, J 5.4, 5-H), 7.15–7.63 (10H18a + 10H19a, m, 20 × ArH), 8.15 (2H18a + 2H19a, br s, 4 × NH); HR-MS (ES) calc. for C24H23N3O6Na (M + Na) 472.1486, found 472.1491; IR (KBr) 3238, 3111, 1714, 1420, 1318, 1221 cm–1.</datasection></text></s></P></DIV></DIV><DIV DEPTH="2"><HEADER>Cycloaddition adducts <XREF ID="chem18b" TYPE="COMPOUND">18b</XREF> and <XREF ID="chem19b" TYPE="COMPOUND">19b</XREF></HEADER><P><s sid="209"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs21" novelty="None" advantage="None"/><text><datasection id="o1678" type="dataSection">Mixture of regioisomers; δH (CDCl3) 0.97–1.15 (6H18b + 6H19b, m, 4 × isopropyl–CH3), 1.32 (9H18b + 9H19b, s, 6 × tertbutyl–CH3), 2.29–2.64 (1H18b + 1H18b, m, isopropyl–CH), 4.36 (1H18b, d, J 5.4, 4-H), 4.54–4.79 (2H18b + 2H19b, m, 2 × –CH2–), 4.85 (1H19b, d, J 4.0, isoxazoline-H), 4.88 (1H19b, d, J 4.0, isozazoline-H), 5.84 (1H18b, d, J 5.4, 5-H), 7.14–7.90 (9H18b + 9H19b, m, 18 × ArH), 8.90 (2H18b + 2H19b, br s, 4 × NH); HR-MS (ES) calc. for C28H31N3O6Na (M + Na) 528.2111, found 528.2110; IR (KBr) 3240, 2967, 1706, 1635, 1317 cm–1.</datasection></text></s></P><DIV DEPTH="3"><HEADER>Cycloaddition adducts <XREF ID="chem18c" TYPE="COMPOUND">18c</XREF> and <XREF ID="chem19c" TYPE="COMPOUND">19c</XREF></HEADER><P><s sid="210"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs22" novelty="None" advantage="None"/><text><datasection id="o1679" type="dataSection">Mixture of regioisomers; δH (CDCl3) 0.90 (6H18c, d, J 6.6, 2 × isopropyl–CH3), 1.01–1.13 (6H19c, m, 2 × isopropyl–CH3), 2.16–2.45 (1H18c + 1H19c, m, 2 × isopropyl–CH), 4.52 (1H18c, d, J 5.2, 4-H), 4.56–4.77 (2H18c + 2H19c, m, 2 × –CH2–), 4.93 (1H19c, d, J 4.0, isoxazoline-H), 5.05 (1H19c, d, J 4.0, isoxazoline-H), 5.96 (1H18c, d, J 5.2, 5-H), 7.14–7.95 (12H18c + 12H19c, m, 24 ArH), 8.41 (2H18c + 2H19c, br s, 4 × NH); HR-MS (ES) calc. for C28H25N306Na (M + Na) 522.1641, found 522.1644; IR (KBr) 3340, 3216, 1762, 1718, 1448, 1313 cm–1.</datasection></text></s></P></DIV><DIV DEPTH="3"><HEADER>Cycloaddition adducts <XREF ID="chem18d" TYPE="COMPOUND">18d</XREF> and <XREF ID="chem19d" TYPE="COMPOUND">19d</XREF></HEADER><P><s sid="211"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs23" novelty="None" advantage="None"/><text><datasection id="o1680" type="dataSection">Mixture of regioisomers; δH (CDCl3) 1.42 (3H18d, s, –CH3), 1.55 (3H19d, s, –CH3), 4.48–4.64 (3H18d + 2H19d, m, 2 × –CH2– and 4-H), 4.94 (1H19d, d, J 4.0, isoxazoline-H), 5.08 (1H19d, d, J 4.0, isozazoline-H), 5.97 (1H18d, d, J 5.0, 5-H), 7.18–7.94 (12H18d + 12H19d, m, 12 × ArH), 8.71 (2H18d + 2H19d, br s, 4 × NH); HR-MS (ES) calc. for C26H21N3O6Na (M + Na) 494.1329, found 494.1323; IR (KBr) 3441, 3232, 3108, 1719, 1456, 1392, 1342 cm–1.</datasection></text></s></P></DIV><DIV DEPTH="3"><HEADER>Cycloaddition adducts <XREF ID="chem18e" TYPE="COMPOUND">18e</XREF> and <XREF ID="chem19e" TYPE="COMPOUND">19e</XREF></HEADER><P><s sid="212"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs24" novelty="None" advantage="None"/><text><datasection id="o1681" type="dataSection">Mixture of regioisomers; δH (CDCl3) 4.58 (1H18e, d, J 5.0, 4-H), 4.79–5.13 (2H18e + 4H19e, m, 2 × –CH2– and 2 × isoxazoline-H), 6.10 (1H18e, d, J 5.0, 5-H), 7.10–8.03 (17H18e + 17H19e, m, 34 × ArH), 8.73 (2H18e + 2H19e, br s, 4 × NH); HR-MS (ES) calc. for C31H23N3O6Na (M + Na) 556.1485, found 556.1496; IR (KBr) 3238, 3111, 1714, 1420, 1318, 1221 cm–1.</datasection></text></s></P></DIV></DIV></DIV></BODY><cmlPile><cml xmlns="http://www.xml-cml.org/schema" id="cml1"><molecule id="m1"><name>2,6-diaminopyridine</name><atomArray><atom id="a1" elementType="N"/><atom id="a2" elementType="C"/><atom id="a3" elementType="C"/><atom id="a4" elementType="C"/><atom id="a5" elementType="C"/><atom id="a6" elementType="C"/><atom id="a7" elementType="N"/><atom id="a8" elementType="N"/></atomArray><bondArray><bond atomRefs2="a1 a2" order="2"/><bond atomRefs2="a2 a3" order="1"/><bond atomRefs2="a3 a4" order="2"/><bond atomRefs2="a4 a5" order="1"/><bond atomRefs2="a5 a6" order="2"/><bond atomRefs2="a6 a1" order="1"/><bond atomRefs2="a7 a2" order="1"/><bond atomRefs2="a8 a6" order="1"/></bondArray></molecule></cml><cmlUrlEnc idRef="cml1">%3Ccml+xmlns%3D%22http%3A%2F%2Fwww.xml-cml.org%2Fschema%22+id%3D%22cml
1%22%3E%3Cmolecule+id%3D%22m1%22%3E%3Cname%3E2%2C6-diaminopyridine%3C%2Fna
me%3E%3CatomArray%3E%3Catom+id%3D%22a1%22+elementType%3D%22N%22+%2F%3E%3Cato
m+id%3D%22a2%22+elementType%3D%22C%22+%2F%3E%3Catom+id%3D%22a3%22+elementT
ype%3D%22C%22+%2F%3E%3Catom+id%3D%22a4%22+elementType%3D%22C%22+%2F%3E%3Catom+id
%3D%22a5%22+elementType%3D%22C%22+%2F%3E%3Catom+id%3D%22a6%22+elementType%3D
%22C%22+%2F%3E%3Catom+id%3D%22a7%22+elementType%3D%22N%22+%2F%3E%3Catom+id%3D%22a8
%22+elementType%3D%22N%22+%2F%3E%3C%2FatomArray%3E%3CbondArray%3E%3Cbond+a
tomRefs2%3D%22a1+a2%22+order%3D%222%22+%2F%3E%3Cbond+atomRefs2%3D%22a2+a
3%22+order%3D%221%22+%2F%3E%3Cbond+atomRefs2%3D%22a3+a4%22+order%3D%222%22+%2F
%3E%3Cbond+atomRefs2%3D%22a4+a5%22+order%3D%221%22+%2F%3E%3Cbond+atomRef
s2%3D%22a5+a6%22+order%3D%222%22+%2F%3E%3Cbond+atomRefs2%3D%22a6+a1%22+ord
er%3D%221%22+%2F%3E%3Cbond+atomRefs2%3D%22a7+a2%22+order%3D%221%22+%2F%3E%3Cbond
+atomRefs2%3D%22a8+a6%22+order%3D%221%22+%2F%3E%3C%2FbondArray%3E%3C%2Fmolec
ule%3E%3C%2Fcml%3E</cmlUrlEnc></cmlPile></PAPER>